Autogenic and Reciprocal Inhibition for Shin Splints in Amateur Football Players
This study aims to evaluate how autogenic and reciprocal inhibition techniques can improve function, reduce pain, and enhance performance in amateur football players suffering from shin splints.
Heating Therapy
+ Manual Soft tissue Release
Leg Injuries+8
+ Muscular Diseases
+ Musculoskeletal Diseases
Treatment Study
Summary
Study start date: December 23, 2023
Actual date on which the first participant was enrolled.This study focuses on understanding how certain muscle energy techniques (METs), such as Autogenic Inhibition and Reciprocal Inhibition, can help amateur football players who suffer from shin splints. Shin splints are a common problem for athletes, often causing pain and limiting their ability to perform. The study aims to explore whether these techniques can effectively reduce pain, improve movement range, and enhance overall function and sports performance. This research is important because while METs have shown success in treating other musculoskeletal conditions, there isn't much information about how they work for sports-related injuries like shin splints. Participants in the study will engage in a structured MET program. These techniques involve specific exercises that help relax muscles and improve flexibility, potentially easing the discomfort of shin splints. The study will measure changes in pain levels, range of motion, and sports performance before and after the intervention to see if there's improvement. By evaluating these outcomes, researchers hope to determine the practical benefits and possible limitations of using METs in sports settings, providing useful guidance for managing and preventing shin injuries in athletes.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.16 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 30 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location